Literature DB >> 16861246

Associations between renal function, volume status and endotoxaemia in chronic kidney disease patients.

Simone Gonçalves1, Roberto Pecoits-Filho, Sônia Perreto, Silvio H Barberato, Andréa E M Stinghen, Emmanuel G A Lima, Roseana Fuerbringer, Sirlene M Sauthier, Miguel C Riella.   

Abstract

Inflammation is an important predictor of increased cardiovascular morbidity and mortality in patients with chronic kidney disease (CKD), but the mechanisms behind the chronic activation of the immune system are not clearly understood. CKD patients develop fluid overload, which has been proposed to be a stimulus for inflammatory activation due to the translocation of macromolecules from the gut. We hypothesize that fluid overload is associated with signs of systemic inflammation and endotoxaemia in stages 1-5 CKD patients. The aim of this prospective study was to evaluate the associations between renal function, fluid status [evaluated by the inferior vena cava diameter (IVCD) and the collapsibility index (CI)], systemic inflammation [plasma levels of C-reactive protein (CRP), fibrinogen and albumin] and endotoxaemia (through the Limulus amebocyte lysate enzymatic assay) in a group of CKD patients in our out-patient clinic. The population consisted of 74 (mean of 57; range 23-83 years of age; 47% males) CKD patients with glomerular filtration rate (based on the mean of urea and creatinine clearances) of 34 ml/min. Both albumin (Rho = 0.25; P = 0.05) and fibrinogen (Rho= - 0.48; P < 0.0001) were significantly correlated to glomerular filtration rate (GFR). According to the IVCD, 84% of the patients were fluid overloaded, while 83% were considered overloaded by the CI. Signs of endotoxaemia were detected in all patients. Endotoxin levels were higher in patients with signs of fluid overload (0.85 +/- 0.11ng/l) when compared with patients with normal values of IVCD (0.61 +/- 0.05 ng/l; P < 0.05). Endotoxin levels correlated to both IVCD (Rho=0.33, P < 0.005) and CI (Rho = -0.25, P < 0.05). There was no correlation between endotoxin levels and GFR, CRP or fibrinogen. In summary, although most CKD patients presented signs of fluid overload that was associated with endotoxaemia, there was no association between endotoxaemia and systemic inflammation, suggesting the endotoxaemia may not be the main determinant of the inflammatory status in this group of patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16861246     DOI: 10.1093/ndt/gfl273

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  44 in total

1.  Role of Nrf2 dysfunction in uremia-associated intestinal inflammation and epithelial barrier disruption.

Authors:  Wei Ling Lau; Shu-Man Liu; Sogol Pahlevan; Jun Yuan; Mahyar Khazaeli; Zhenmin Ni; Jefferson Y Chan; Nosratola D Vaziri
Journal:  Dig Dis Sci       Date:  2014-11-16       Impact factor: 3.199

2.  Circulating endotoxemia: a novel factor in systemic inflammation and cardiovascular disease in chronic kidney disease.

Authors:  Christopher W McIntyre; Laura E A Harrison; M Tarek Eldehni; Helen J Jefferies; Cheuk-Chun Szeto; Stephen G John; Mhairi K Sigrist; James O Burton; Daljit Hothi; Shvan Korsheed; Paul J Owen; Ka-Bik Lai; Philip K T Li
Journal:  Clin J Am Soc Nephrol       Date:  2010-09-28       Impact factor: 8.237

3.  Associations between nutritional markers and inflammation in hemodialysis patients.

Authors:  Franciele D Vannini; Aline A Antunes; Jacqueline C T Caramori; Luis C Martin; Pasqual Barretti
Journal:  Int Urol Nephrol       Date:  2009-12       Impact factor: 2.370

4.  Associations of Soluble CD14 and Endotoxin with Mortality, Cardiovascular Disease, and Progression of Kidney Disease among Patients with CKD.

Authors:  Ruben Poesen; Ali Ramezani; Kathleen Claes; Patrick Augustijns; Dirk Kuypers; Ian R Barrows; Jagadeesan Muralidharan; Pieter Evenepoel; Björn Meijers; Dominic S Raj
Journal:  Clin J Am Soc Nephrol       Date:  2015-07-07       Impact factor: 8.237

5.  Examining associations of circulating endotoxin with nutritional status, inflammation, and mortality in hemodialysis patients.

Authors:  Usama Feroze; Kamyar Kalantar-Zadeh; Kevin A Sterling; Miklos Z Molnar; Nazanin Noori; Debbie Benner; Vallabh Shah; Rama Dwivedi; Kenneth Becker; Csaba P Kovesdy; Dominic S Raj
Journal:  J Ren Nutr       Date:  2011-08-31       Impact factor: 3.655

Review 6.  An update on the role of the inflammasomes in the pathogenesis of kidney diseases.

Authors:  Murthy N Darisipudi; Felix Knauf
Journal:  Pediatr Nephrol       Date:  2015-07-16       Impact factor: 3.714

Review 7.  Intestinal Microbiota in Type 2 Diabetes and Chronic Kidney Disease.

Authors:  Alice Sabatino; Giuseppe Regolisti; Carmela Cosola; Loreto Gesualdo; Enrico Fiaccadori
Journal:  Curr Diab Rep       Date:  2017-03       Impact factor: 4.810

8.  Role of urea in intestinal barrier dysfunction and disruption of epithelial tight junction in chronic kidney disease.

Authors:  Nosratola D Vaziri; Jun Yuan; Keith Norris
Journal:  Am J Nephrol       Date:  2012-12-19       Impact factor: 3.754

Review 9.  The gut microbiome, kidney disease, and targeted interventions.

Authors:  Ali Ramezani; Dominic S Raj
Journal:  J Am Soc Nephrol       Date:  2013-11-14       Impact factor: 10.121

10.  Does low peritoneal glucose load protect from the development of left ventricular hypertrophy in peritoneal dialysis patients?

Authors:  Kamal Hassan; Fadi Hassan; Dunia Hassan; Saab Anwar; Hassan Shadi
Journal:  Clin Exp Nephrol       Date:  2015-11-22       Impact factor: 2.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.